Advertisement
Advertisement
IMMP
Immutep Limited - ADR
0.39
USDSponsored
+0.01
+2.85%
Aug 07, 15:58 UTC -4
Closed
After-Market
0.39
0.00
-0.21%
IMMP Earnings Reports
Positive Surprise Ratio
IMMP beat 6 of 10 last estimates.
60%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Immutep Limited - ADR earnings per share and revenue
On Jul 29, 2026, IMMP reported earnings of -- USD per share (EPS) for Q4 26, -- the estimate of 0.00 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 12.06 million, with a --% difference. The market reacted with a -0.26% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ANI Pharmaceuticals, Inc.
Report Date
Aug 07, 2026 For Q2 26
Estimate
$2.09
Actual
$2.21
Surprise
+5.69%
Zymeworks Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.46
Actual
-$0.62
Surprise
-32.31%
Intellia Therapeutics, Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.81
Actual
-$0.80
Surprise
+1.86%
Monte Rosa Therapeutics, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.39
Actual
-$0.43
Surprise
-9.58%
CytomX Therapeutics, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.07
Actual
-$0.09
Surprise
-13.78%
Verastem, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.44
Actual
-$0.35
Surprise
+20.69%
ALX Oncology Holdings Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.14
Actual
-$0.13
Surprise
+11.08%
Arcturus Therapeutics Holdings Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$1.01
Actual
-$0.84
Surprise
+17.53%
Entera Bio Ltd. Ordinary Shares
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.14
Surprise
-71.57%
Cytokinetics Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$1.67
Actual
-$1.50
Surprise
+10.35%
FAQ
What were Immutep Limited - ADR's earnings and revenue for the latest quarter Q4 2026?
For Q4 2026, Immutep Limited - ADR reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Immutep Limited - ADR's Q4 2026 earnings?
The stock price moved down -0.26%, changed from $0.38 before the earnings release to $0.38 the day after.
When is Immutep Limited - ADR expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Immutep Limited - ADR's next earnings report?
Based on --
analysts, Immutep Limited - ADR is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement